In several rodent models of experimental autoimmune encephalomyelitis (EAE), which is often used as a model for human MS, ghrelin has been shown to reduce the disease severity and associated neuroinflammation [74,203]. Here, GHRL is linked to experimental autoimmune encephalomyelitis.